JAGX Jaguar Health Inc

Price (delayed)

$3.05

Market cap

$1.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$605.6

Enterprise value

$26.09M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 26

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating ...

Highlights
Jaguar Health's gross profit has surged by 164% YoY
The company's revenue has surged by 157% QoQ and by 156% YoY

Key stats

What are the main financial stats of JAGX

JAGX stock price

How has the Jaguar Health stock price performed over time
Intraday
4.45%
1 week
-7.29%
1 month
-6.15%
1 year
-97.82%
YTD
-90.64%
QTD
-76.48%

Financial performance

How have Jaguar Health's revenue and profit performed over time
Revenue
$29.57M
Gross profit
$25.15M
Operating income
-$26.31M
Net income
-$34.12M
Gross margin
85.1%
Net margin
-115.4%
Jaguar Health's gross profit has surged by 164% YoY
The company's revenue has surged by 157% QoQ and by 156% YoY
JAGX's operating margin has soared by 78% from the previous quarter and by 68% YoY
JAGX's net margin has surged by 75% since the previous quarter and by 66% year-on-year

Price vs fundamentals

How does JAGX's price correlate with its fundamentals

Growth

What is Jaguar Health's growth rate over time

Valuation

What is Jaguar Health stock price valuation
P/E
N/A
P/B
N/A
P/S
0.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
The EPS has soared by 81% YoY and by 25% QoQ
The equity rose by 18% QoQ
The company's revenue has surged by 157% QoQ and by 156% YoY
The price to sales (P/S) is 99% lower than the 5-year quarterly average of 4.1 and 75% lower than the last 4 quarters average of 0.2

Efficiency

How efficient is Jaguar Health business performance
The return on invested capital has dropped by 76% year-on-year but it has increased by 11% since the previous quarter
The ROS has soared by 76% QoQ and by 68% YoY
The company's return on assets has shrunk by 64% YoY

Dividends

What is JAGX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for JAGX.

Financial health

How did Jaguar Health financials performed over time
JAGX's total assets is 30% smaller than its total liabilities
Jaguar Health's current ratio has plunged by 54% YoY
JAGX's total assets is down by 27% year-on-year and by 2.3% since the previous quarter
The debt to equity has plunged by 111% YoY but it has grown by 4% from the previous quarter
JAGX's debt is down by 21% since the previous quarter and by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.